Evaluation of inhaled recombinant human insulin dry powders: pharmacokinetics, pharmacodynamics and 14-day inhalation.

Jiake HeGe ZhangQiuyang ZhangJiayin ChenYongjie ZhangXiaoxia AnPan WangShan XieFang FangJianheng ZhengYue TangJiabi ZhuYang YuXijing Chen Yang Lu

Published in: The Journal of pharmacy and pharmacology (2018)

Both PS- and PHT-loaded rh-insulin dry powders were able to deliver rh-insulin systemically with appropriate pharmacokinetic, pharmacodynamic and safety profiles.

Keyphrases

type diabetes
recombinant human
glycemic control
drug delivery
cystic fibrosis
cancer therapy
metabolic syndrome
adipose tissue
insulin resistance
skeletal muscle